Fenofibrate is a fibric acid derivative whose
lipid modifying effects reported in humans are mediated via
activation of Peroxisome Proliferator Activated Receptor type
alpha (PPARa). Through activation of PPARa, fenofibrate increases
the lipolysis and elimination of atherogenic triglyceride-rich
particles from plasma by activating lipoprotein lipase and
reducing production of apoprotein CIII. Activation of PPARa
also induces an increase in the synthesis of apoproteins AI
are available in blister pack of 30's.
Capsules 200mg are available in blister pack of 10's.